Theranos Investigation Continues As COO Out At FirmMark Melin
The Theranos investigation is likely in the deliberative stage, determining what corrective action might be taken for a company that operated on the edge. In this environment a sacrifice might have occurred as the chief operating officer and one of the original architects of the company's system leaves the firm.
One of the primary Theranos executives targeted by regulators with a potential ban from the medical testing industry, COO Ramesh (Sunny) Balwani, is departing the blood testing firm. The company is under both regulatory and criminal investigations related to . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.